LRI Investments’s Indivior Pharmaceuticals INDV Stock Holding History

LRI Investments’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123	Buy	+3	New	+$109	﹤0.01%	1823

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LRI Investments's INDV Position: Q2 2026 in Review

LRI Investments opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 3 shares worth $123. The stake represents ﹤0.01% of the portfolio and ranks #1823 among its holdings.

70 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

LRI Investments held 3 shares of Indivior Pharmaceuticals worth $123 as of Q2 2026.
Indivior Pharmaceuticals was a new LRI Investments position in Q2 2026.
Indivior Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1823 holding.
70 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.